An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Iterum Therapeutics plc. Investors who are current long term investors in Iterum Therapeutics plc (NASDAQ: ITRM) shares, have certain options and should contact theInvestigation announced for Long-Term Investors in shares of Iterum Therapeutics plc (NASDAQ: ITRM) | openPR.com - New Public Relations: Business, Economy, Finances, Banking & Insurance
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Iterum Therapeutics plc. Investors who are current long term investors in Iterum Therapeutics plc (NASDAQ: ITRM) shares, have certain options and should contact the